Article info

Download PDFPDF
Original research
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease

Authors

  1. Correspondence to Professor Rohit Loomba, Department of Medicine, University of California San Diego, La Jolla CA 92037, USA; roloomba{at}ucsd.edu
View Full Text

Citation

Tamaki N, Munaganuru N, Jung J, et al
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease

Publication history

  • Received January 30, 2021
  • Revised March 25, 2021
  • Accepted April 8, 2021
  • First published April 21, 2021.
Online issue publication 
April 08, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.